Laughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.


Phase N/A Results N/A

Summary of Purpose

This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following neurological conditions: Alzheimer's disease, amyotrophic lateral sclerosis, brain injury, Huntington's Disease, multiple sclerosis, Parkinson's Disease, post-stroke, spinal cord injury.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 18 January 2018.

1 Jul 2016 21 Apr 2016 1 Aug 2018 1 Dec 2018 1 Jan 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics


Conditions See All


Trial Design

  • Masking: Open Label
  • Purpose: Health Services Research
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment